Copyright © 2009 V. R. M. Lombardi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. N. Arulrayan, S. Rangasamy, E. James, and D. Pitchai, “A database for medicinal plants used in the treatment of diabetes and its secondary complications,” Bioinformation, vol. 2, pp. 22–23, 2007.
2. B. Kasirajan, R. Maruthamuthu, V. Gopalakrishnan, et al., “A database for medicinal plants used in treatment of asthma,” Bioinformation, vol. 2, no. 3, pp. 105–106, 2007.
3. A. M. S. Mayer, A. D. Rodríguez, R. G. S. Berlinck, and M. T. Hamann, “Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action,” Comparative Biochemistry and Physiology C, vol. 145, pp. 553–581, 2007.
4. L. C. Tapsell, I. Hemphill, L. Cobiac, et al., “Health benefits of herbs and spices: the past, the present, the future,” The Medical Journal of Australia, vol. 185, no. 4, supplement, pp. S4–S24, 2006.
5. B.-B. Lee, M.-R. Cha, S.-Y. Kim, E. Park, H.-R. Park, and S.-C. Lee, “Antioxidative and anticancer activity of extracts of cherry (Prunus serrulata var. spontanea) blossoms,” Plant Foods for Human Nutrition, vol. 62, no. 2, pp. 79–84, 2007. View at Publisher · View at Google Scholar · View at PubMed
6. H.-C. Ko, Y.-H. Wang, K.-T. Liou, et al., “Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells,” European Journal of Pharmacology, vol. 555, no. 2-3, pp. 211–217, 2007. View at Publisher · View at Google Scholar · View at PubMed
7. C. Härtel, P. Iblher, A. Puzik, et al., “Immunosuppressive activity of the immunophilin-binding drug sanglifehrin A in human whole blood: potent inhibition of interleukin-6 produced by lymphocytes and monocytes,” Scandinavian Journal of Immunology, vol. 63, no. 1, pp. 26–34, 2006. View at Publisher · View at Google Scholar · View at PubMed
8. F. Lara-Villoslada, M. Olivares, S. Sierra, J. M. Rodríguez, J. Boza, and J. Xaus, “Beneficial effects of probiotic bacteria isolated from breast milk,” British Journal of Nutrition, vol. 98, pp. S96–S100, 2007. View at Publisher · View at Google Scholar · View at PubMed
9. S. Bengmark and A. Gil, “Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics,” Nutricion Hospitalaria, vol. 21, pp. 73–86, 2006.
10. J. L. Jordan, A. M. Sullivan, and T. D. G. Lee, “Immune activation by a sterile aqueous extract of Cordyceps sinensis: mechanism of action,” Immunopharmacology and Immunotoxicology, vol. 30, no. 1, pp. 53–70, 2008. View at Publisher · View at Google Scholar · View at PubMed
11. E. Savilahti, M. Kuitunen, and O. Vaarala, “Pre and probiotics in the prevention and treatment of food allergy,” Current Opinion in Allergy and Clinical Immunology, vol. 8, no. 3, pp. 243–248, 2008. View at Publisher · View at Google Scholar · View at PubMed
12. K. Hatakka and M. Saxelin, “Probiotics in intestinal and non-intestinal infectious diseases—clinical evidence,” Current Pharmaceutical Design, vol. 14, no. 14, pp. 1351–1367, 2008. View at Publisher · View at Google Scholar
13. C. Steurer-Stey, L. M. Bachmann, J. Steurer, and M. R. Tramèr, “Oral purified bacterial extracts in chronic brochitis and COPD: systematic review,” Chest, vol. 126, no. 5, pp. 1645–1655, 2004. View at Publisher · View at Google Scholar · View at PubMed
14. F. Braido, F. Tarantini, V. Ghiglione, G. Melioli, and G. W. Canonica, “Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections,” International Journal of COPD, vol. 2, no. 3, pp. 335–345, 2007.
15. M. Cazzola, P. Rogliani, and G. Curradi, “Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of view,” Respiratory Medicine, vol. 102, no. 3, pp. 321–327, 2008. View at Publisher · View at Google Scholar · View at PubMed
16. C. Arandjus, P. N. Black, P. J. Poole, R. Wood Baker, and C. Steurer-Stey, “Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis,” Respiratory Medicine, vol. 100, no. 10, pp. 1671–1681, 2006. View at Publisher · View at Google Scholar · View at PubMed
17. J. P. Collet, S. Shapiro, P. Ernst, et al., “Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 6, pp. 1719–1724, 1997.
18. G. Lanzilli, R. Falchetti, M. Tricarico, D. Ungheri, and M. P. Fuggetta, “In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function,” International Journal of Immunopathology and Pharmacology, vol. 18, no. 2, pp. 245–254, 2005.
19. G. Lanzilli, R. Falchetti, A. Cottarelli, A. Macchi, D. Ungheri, and M. P. Fuggetta, “In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes,” International Journal of Immunopathology and Pharmacology, vol. 19, no. 3, pp. 551–559, 2006.
20. J.-H. Park, J.-I. Um, B.-J. Lee, et al., “Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production,” Cellular Immunology, vol. 219, no. 1, pp. 22–27, 2002. View at Publisher · View at Google Scholar
21. A. de Moreno de LeBlanc, S. Chaves, E. Carmuega, R. Weill, J. Antóine, and G. Perdigón, “Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages,” Immunobiology, vol. 213, no. 2, pp. 97–108, 2008. View at Publisher · View at Google Scholar · View at PubMed
22. M. P. Díaz-Ropero, R. Martín, S. Sierra, et al., “Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response,” Journal of Applied Microbiology, vol. 102, no. 2, pp. 337–343, 2007. View at Publisher · View at Google Scholar · View at PubMed
23. F. J. Penna, L. A. Péret, L. Q. Vieira, and J. R. Nicoli, “Probiotics and mucosal barrier in children,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 11, no. 5, pp. 640–644, 2008.
24. S. H. Khan and F. A. Ansari, “Probiotics—the friendly bacteria with market potential in global market,” Pakistan Journal of Pharmaceutical Sciences, vol. 20, no. 1, pp. 76–82, 2007.
25. S. Macfarlane, G. T. Macfarlane, and J. H. Cummings, “Review article: prebiotics in the gastrointestinal tract,” Alimentary Pharmacology and Therapeutics, vol. 24, no. 5, pp. 701–714, 2006. View at Publisher · View at Google Scholar · View at PubMed
26. G. Blandino, D. Fazio, and R. Di Marco, “Probiotics: overview of microbiological and immunological characteristics,” Expert Review of Anti-Infective Therapy, vol. 6, no. 4, pp. 497–508, 2008. View at Publisher · View at Google Scholar · View at PubMed
27. M. de Vrese and J. Schrezenmeir, “Probiotics, prebiotics, and synbiotics,” Advances in Biochemical Engineering/Biotechnology, vol. 111, pp. 1–66, 2008. View at Publisher · View at Google Scholar · View at PubMed
28. G. R. Gibson, “Prebiotics as gut microflora management tools,” Journal of Clinical Gastroenterology, vol. 42, pp. S75–S79, 2008.
29. K. Madsen, “Probiotics and the immune response,” Journal of Clinical Gastroenterology, vol. 40, no. 3, pp. 232–234, 2006. View at Publisher · View at Google Scholar
30. F. Lutgendorff, L. M. A. Akkermans, and J. D. Söderholm, “The role of microbiota and probiotics in stress-induced gastrointestinal damage,” Current Molecular Medicine, vol. 8, no. 4, pp. 282–298, 2008. View at Publisher · View at Google Scholar
31. Y. Kim, S.-H. Kim, K.-Y. Whang, Y.-J. Kim, and S. Oh, “Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells,” Journal of Microbiology and Biotechnology, vol. 18, no. 7, pp. 1278–1285, 2008.
32. J. K. Spinler, M. Taweechotipatr, C. L. Rognerud, C. N. Ou, S. Tumwasorn, and J. Versalovic, “Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens,” Anaerobe, vol. 14, no. 3, pp. 166–171, 2008. View at Publisher · View at Google Scholar · View at PubMed
33. E. Isolauri and S. Salminen, “Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report,” Journal of Clinical Gastroenterology, vol. 42, pp. S91–S96, 2008.
34. J. Armitage, J. Vose, and D. Weisenburger, “International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project,” Journal of Clinical Oncology, vol. 26, no. 25, pp. 4124–4130, 2008. View at Publisher · View at Google Scholar · View at PubMed
35. D. Barnett, B. Walker, A. Landay, and T. N. Denny, “CD4 immunophenotyping in HIV infection,” Nature Reviews Microbiology, vol. 6, pp. S7–S15, 2008. View at Publisher · View at Google Scholar · View at PubMed
36. F. M. Cady and W. G. Morice, “Flow cytometric assessment of T-cell chronic lymphoproliferative disorders,” Clinics in Laboratory Medicine, vol. 27, no. 3, pp. 513–532, 2007. View at Publisher · View at Google Scholar · View at PubMed
37. W. B. Lindsey, M. W. Lowdell, G. E. Marti, et al., “CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery,” Cytotherapy, vol. 9, no. 2, pp. 123–132, 2007. View at Publisher · View at Google Scholar · View at PubMed
38. D. Kingkeow, C. M. Heilig, C. Costello, et al., “Lymphocyte homeostasis in HIV-infected northern Thais,” AIDS Research and Human Retroviruses, vol. 20, no. 6, pp. 636–641, 2004. View at Publisher · View at Google Scholar · View at PubMed
39. S. Wang, “The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway,” Oncogene, vol. 27, no. 48, pp. 6207–6215, 2008. View at Publisher · View at Google Scholar · View at PubMed
40. R. W. Johnstone, A. J. Frew, and M. J. Smyth, “The TRAIL apoptotic pathway in cancer onset, progression and therapy,” Nature Reviews Cancer, vol. 8, no. 10, pp. 782–798, 2008. View at Publisher · View at Google Scholar · View at PubMed
41. V. Thorns, G. F. Walter, and F. Licastro, “Effects of IL6 and IL1$\beta$ on aFGF expression and excitotoxicity in NT2N cells,” Journal of Neuroimmunology, vol. 127, no. 1-2, pp. 22–29, 2002. View at Publisher · View at Google Scholar
42. M. Wang, Z. Xie, M. Shi, et al., “A new strategy to induce effective antitumour response in vitro and in vivo,” Scandinavian Journal of Immunology, vol. 68, no. 3, pp. 287–296, 2008. View at Publisher · View at Google Scholar · View at PubMed
43. D. Ghadimi, R. Fölster-Holst, M. de Vrese, P. Winkler, K. J. Heller, and J. Schrezenmeir, “Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects,” Immunobiology, vol. 213, no. 8, pp. 677–692, 2008. View at Publisher · View at Google Scholar · View at PubMed
44. E. J. Cheadle, D. E. Gilham, and R. E. Hawkins, “The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma,” British Journal of Haematology, vol. 142, no. 1, pp. 65–68, 2008. View at Publisher · View at Google Scholar · View at PubMed
45. W. D. Y. Quan, Jr., F. M. Quan, L. A. King, and P. R. Walker, “Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer,” Cancer Biotherapy and Radiopharmaceuticals, vol. 23, no. 1, pp. 108–113, 2008. View at Publisher · View at Google Scholar · View at PubMed
46. L. Bracci, F. Moschella, P. Sestili, et al., “Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration,” Clinical Cancer Research, vol. 13, no. 2, pp. 644–653, 2007. View at Publisher · View at Google Scholar · View at PubMed